The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
MJFF Research Grant, 2010Optimization of Optical Coherence Tomography as a Biomarker for Parkinson's Disease
Objective/Rationale:
Determine the thickness of the neural part of the eye, the retina in patients suffering from Parkinson Disease and in healthy, age matched subjects.Project Description:
Patients... -
MJFF Research Grant, 2009Neoangiogenesis and blood-brain barrier in L-DOPA-induced dyskinesia
Promising Outcomes of Original Grant:
Working on a pre-clinical model of Parkinson´s disease, we have found that levodopa treatment induces proliferation of endothelial cells and angiogenesis in the... -
MJFF Research Grant, 2009Specific Inhibition of Nucleation of Alpha-Synuclein Aggregation as a Therapeutic Strategy
The discovery of specific genes associated with rare, genetic forms of Parkinson’s disease has opened the opportunity to investigate the mechanisms of the disease and to develop novel drugs. Parkinson...
-
MJFF Research Grant, 2010Making PSG Databases Available to Researchers
Objective/Rationale:
Information from clinical trials is not easily available to most researchers, especially if the trials are sponsored by industry. Making information from clinical trials more... -
Understanding LRRK2 Biology, 2009Building a LRRK2 Cohort Core Database
Objective/Rationale:
MJFF is funding the expansion of two international LRRK2 cohorts to gain insight into the relationship of this genetic mutation to Parkinson’s disease. Within each funded study... -
MJFF Research Grant, 2008Developing New Antibodies for a Standardized Alpha-Synuclein Assay (ELISA)
Objective/Rationale:
To raise and characterize new antibodies in vertebrate animals that allow for the routine measurement of a key protein linked to Parkinson disease, alpha-synuclein. A renewable...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.